Literature DB >> 7193870

In vitro drug assay: pharmacologic considerations.

D S Alberts, H S Chen, S E Salmon.   

Abstract

Mesh:

Substances:

Year:  1980        PMID: 7193870

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


× No keyword cloud information.
  7 in total

1.  Comparative effect of cisplatin, spiroplatin, carboplatin and iproplatin in a human tumor clonogenic assay.

Authors:  W Schroyens; P Dodion; M Rozencweig
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  Collagen gel culture of rat mammary tumor cells as an assay system for determination of therapeutic efficacy of chemotherapeutic agents.

Authors:  D K Sinha; C J White
Journal:  In Vitro Cell Dev Biol       Date:  1988-06

Review 3.  Ex Vivo Culture of CTCs: An Emerging Resource to Guide Cancer Therapy.

Authors:  Shyamala Maheswaran; Daniel A Haber
Journal:  Cancer Res       Date:  2015-05-21       Impact factor: 12.701

4.  Comparison of in vitro activity of epipodophyllotoxins with other chemotherapeutic agents in human medulloblastomas.

Authors:  F H Tomlinson; M G Lihou; P J Smith
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

5.  Enhancement of cytotoxicity of vindesine and cis-platinum for human lung tumours by the use of verapamil in vitro.

Authors:  A P Simmonds; P Moyes; A Nicol; K G Davidson; A Faichney
Journal:  Br J Cancer       Date:  1986-12       Impact factor: 7.640

6.  The human tumour cloning assay in the management of breast cancer patients.

Authors:  C Dittrich; R Jakesz; F Wrba; L Havelec; O Haas; J Spona; H Holzner; R Kolb; K Moser
Journal:  Br J Cancer       Date:  1985-08       Impact factor: 7.640

7.  Vidarabin-monophosphate, BCNU, VM26--an in vitro comparative study of active agents in the treatment of malignant human brain tumours.

Authors:  U Bogdahn; J Zapf; H Weber; G Dünisch; H G Löbering; R Martin; H G Mertens
Journal:  Br J Cancer       Date:  1987-02       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.